These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 8205701

  • 1. Effects of long-term monotherapy with enalapril, metoprolol, and digoxin on the progression of left ventricular dysfunction and dilation in dogs with reduced ejection fraction.
    Sabbah HN, Shimoyama H, Kono T, Gupta RC, Sharov VG, Scicli G, Levine TB, Goldstein S.
    Circulation; 1994 Jun; 89(6):2852-9. PubMed ID: 8205701
    [Abstract] [Full Text] [Related]

  • 2. Ranolazine combined with enalapril or metoprolol prevents progressive LV dysfunction and remodeling in dogs with moderate heart failure.
    Rastogi S, Sharov VG, Mishra S, Gupta RC, Blackburn B, Belardinelli L, Stanley WC, Sabbah HN.
    Am J Physiol Heart Circ Physiol; 2008 Nov; 295(5):H2149-55. PubMed ID: 18820026
    [Abstract] [Full Text] [Related]

  • 3. Effects of long-term therapy with bosentan on the progression of left ventricular dysfunction and remodeling in dogs with heart failure.
    Mishima T, Tanimura M, Suzuki G, Todor A, Sharov VG, Goldstein S, Sabbah HN.
    J Am Coll Cardiol; 2000 Jan; 35(1):222-9. PubMed ID: 10636284
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of long-term monotherapy with metoprolol CR/XL on the progression of left ventricular dysfunction and remodeling in dogs with chronic heart failure.
    Morita H, Suzuki G, Mishima T, Chaudhry PA, Anagnostopoulos PV, Tanhehco EJ, Sharov VG, Goldstein S, Sabbah HN.
    Cardiovasc Drugs Ther; 2002 Sep; 16(5):443-9. PubMed ID: 12652114
    [Abstract] [Full Text] [Related]

  • 7. Effects of dopamine beta-hydroxylase inhibition with nepicastat on the progression of left ventricular dysfunction and remodeling in dogs with chronic heart failure.
    Sabbah HN, Stanley WC, Sharov VG, Mishima T, Tanimura M, Benedict CR, Hegde S, Goldstein S.
    Circulation; 2000 Oct 17; 102(16):1990-5. PubMed ID: 11034950
    [Abstract] [Full Text] [Related]

  • 8. Effects of long-term monotherapy with eplerenone, a novel aldosterone blocker, on progression of left ventricular dysfunction and remodeling in dogs with heart failure.
    Suzuki G, Morita H, Mishima T, Sharov VG, Todor A, Tanhehco EJ, Rudolph AE, McMahon EG, Goldstein S, Sabbah HN.
    Circulation; 2002 Dec 03; 106(23):2967-72. PubMed ID: 12460880
    [Abstract] [Full Text] [Related]

  • 9. Effects of long-term therapy with enalapril on severity of functional mitral regurgitation in dogs with moderate heart failure.
    Shimoyama H, Sabbah HN, Rosman H, Kono T, Alam M, Goldstein S.
    J Am Coll Cardiol; 1995 Mar 01; 25(3):768-72. PubMed ID: 7860927
    [Abstract] [Full Text] [Related]

  • 10. Effects of chronic neutral endopeptidase inhibition on the progression of left ventricular dysfunction and remodeling in dogs with moderate heart failure.
    Mishima T, Tanimura M, Suzuki G, Todor A, Sharov VG, Tanhehco EJ, Goldstein S, Sabbah HN.
    Cardiovasc Drugs Ther; 2002 May 01; 16(3):209-14. PubMed ID: 12374898
    [Abstract] [Full Text] [Related]

  • 11. Long-term pharmacological activation of PPARgamma does not prevent left ventricular remodeling in dogs with advanced heart failure.
    Suzuki G, Khanal S, Rastogi S, Morita H, Mishima T, Anagnostopoulos PV, Nass O, Sharov VG, Tanhehco EJ, Goldstein S, Sabbah HN.
    Cardiovasc Drugs Ther; 2007 Feb 01; 21(1):29-36. PubMed ID: 17294127
    [Abstract] [Full Text] [Related]

  • 12. Effects of AT1-receptor blockade on progression of left ventricular dysfunction in dogs with heart failure.
    Tanimura M, Sharov VG, Shimoyama H, Mishima T, Levine TB, Goldstein S, Sabbah HN.
    Am J Physiol; 1999 Apr 01; 276(4):H1385-92. PubMed ID: 10199866
    [Abstract] [Full Text] [Related]

  • 13. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. SOLVD (Studies of Left Ventricular Dysfunction) Investigators.
    Konstam MA, Kronenberg MW, Rousseau MF, Udelson JE, Melin J, Stewart D, Dolan N, Edens TR, Ahn S, Kinan D.
    Circulation; 1993 Nov 01; 88(5 Pt 1):2277-83. PubMed ID: 8222122
    [Abstract] [Full Text] [Related]

  • 14. Effect of beta-blockade on left atrial contribution to ventricular filling in dogs with moderate heart failure.
    Shimoyama H, Sabbah HN, Rosman H, Alam M, Goldstein S.
    Am Heart J; 1996 Apr 01; 131(4):772-7. PubMed ID: 8721654
    [Abstract] [Full Text] [Related]

  • 15. Atenolol is inferior to metoprolol in improving left ventricular function and preventing ventricular remodeling in dogs with heart failure.
    Zacà V, Rastogi S, Mishra S, Wang M, Sharov VG, Gupta RC, Goldstein S, Sabbah HN.
    Cardiology; 2009 Apr 01; 112(4):294-302. PubMed ID: 18832825
    [Abstract] [Full Text] [Related]

  • 16. Benefit of converting enzyme inhibition on left ventricular volumes and ejection fraction in patients receiving beta-blockade after myocardial infarction. CONSENSUS II multiecho study group.
    Bonarjee VV, Carstensen S, Caidahl K, Nilsen DW, Edner M, Lindvall K, Snapinn SM, Berning J.
    Am Heart J; 1996 Jul 01; 132(1 Pt 1):71-7. PubMed ID: 8701878
    [Abstract] [Full Text] [Related]

  • 17. Cellular basis for improved left ventricular pump function after digoxin therapy in experimental left ventricular failure.
    McMahon WS, Holzgrefe HH, Walker JD, Mukherjee R, Arthur SR, Cavallo MJ, Child MJ, Spinale FG.
    J Am Coll Cardiol; 1996 Aug 01; 28(2):495-505. PubMed ID: 8800131
    [Abstract] [Full Text] [Related]

  • 18. Selective matrix metalloproteinase inhibition attenuates progression of left ventricular dysfunction and remodeling in dogs with chronic heart failure.
    Morita H, Khanal S, Rastogi S, Suzuki G, Imai M, Todor A, Sharov VG, Goldstein S, O'Neill TP, Sabbah HN.
    Am J Physiol Heart Circ Physiol; 2006 Jun 01; 290(6):H2522-7. PubMed ID: 16428338
    [Abstract] [Full Text] [Related]

  • 19. Darbepoetin-alpha prevents progressive left ventricular dysfunction and remodeling in nonanemic dogs with heart failure.
    Rastogi S, Imai M, Sharov VG, Mishra S, Sabbah HN.
    Am J Physiol Heart Circ Physiol; 2008 Dec 01; 295(6):H2475-82. PubMed ID: 18952719
    [Abstract] [Full Text] [Related]

  • 20. Effects of ACE inhibition on cardiomyocyte apoptosis in dogs with heart failure.
    Goussev A, Sharov VG, Shimoyama H, Tanimura M, Lesch M, Goldstein S, Sabbah HN.
    Am J Physiol; 1998 Aug 01; 275(2):H626-31. PubMed ID: 9683452
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.